Rapid Communication
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 7, 2006; 12(45): 7337-7340
Published online Dec 7, 2006. doi: 10.3748/wjg.v12.i45.7337
Table 1 Ratio of cut-off value and optical density (A450 nm) of the sample (or Co/S)
Co/SInterpretation
< 0.9Negative
0.9-1.1Equivocal
> 1.1Positive
Table 2 Rate of seroconversion in patients and controls 1 and 6 mo after 1st dose and 1 mo after 2nd dose of HA vaccine
TimePatients(n = 11)
Controls(n = 13)
P
n (%)n (%)
1 mo after the 1st dose of HA vaccine
Positive7 (63.6)13 (100)0.07
Equivocal2 (18.2)0
Negative2 (18.2)0
6 mo after the 1st dose of HA vaccine
Positive7 (63.6)13 (100)0.09
Equivocal3 (27.3)0
Negative1 (9.1)0
1 mo after the 2nd (booster) dose of HA vaccine
Positive11 (100)13 (100)0.63
Equivocal00
Negative00
Table 3 Comparison of the mean value of seroconversion (Co/S) between patients and controls
TimePatients (n = 11)
Controls (n = 13)
RangeMean ± SDRangeMean ± SD
1 mo after the 1st dose of HA vaccine0.6-1.61.1 ± 0.41.5-3.62.5 ± 0.97
6 mo after the 1st dose of HA vaccine0.9-4.83 ± 1.32.3-6.94.7 ± 1.8
1 mo after the 2nd (booster) dose of HA vaccine3.2-5.34.6 ± 0.84.2-5.74.9 ± 0.7
PbP = 0.003aP = 0.02
Table 4 Comparison of liver function tests before and after vaccination
Before vaccination
After vaccination
P
RangeMedianRangeMedian
Patients
Total Serum Bilirubin (mg/L)4-21073-2507.59.5
ALT (IU/L)19-1634219-13627.50.11
AST (IU/L)28-2993830-288430.07
Controls
Total Serum Bilirubin (mg/L)3-651-644.8
ALT (IU/L)9-211810-27170.93
AST (IU/L)21-392721-57310.01b
Table 5 Comparison of differences in liver functions before and after vaccination between patients and controls (mean ± SD)
Bilirubin (mg/L)ALT (IU/L)AST (IU/L)
Patients0.8 ± 17-11.3 ± 2614.8 ± 23.8
Controls-0.18 ± 0.90.54 ± 7.35.1 ± 6.8
P0.920.03a0.58